Xentria Inc. Where Innovation and Success Converge

The Xentria trial is a Phase 1b/2 study of XTMAB-16 in patients with pulmonary sarcoidosis. See below for information about the trial sites for this clinical ... company logo. XENTRIA INC. 2 of 2 Job Opportunities. All Departments. All Locations. Job, Post Date , Department. Perkins Coie is pleased to have advised Xentria Inc., a clinical-stage biotherapeutics company dedicated to developing novel therapeutics to address unmet ... Essential stats, news, real-time insights on Xentria, Inc.. Connect with decision makers, founders, investors. Explore valuation, funding rounds, reviews. Get regular updates to your inbox. ... Bionews, Inc. ... This site is strictly a news and information website about the disease. It does not provide ... Xentria is a pioneering biopharmaceutical company focused on developing biologic and innovative drug therapies. Their investigational drug, XTMAB-16, is a ... Clinical study for Study to Compare the Efficacy, Pharmacokinetics, Pharmacodynamics, Safety, and Immunogenicity of MAB-22 Versus Prolia® 19, 2024 /PRNewswire/ -- Xentria, Inc. (Xentria), a clinical-stage biotherapeutics company focused on advancing drug development to address ... Xentria. Founded 2020; Website Categories (key): BP, BS, AN. Locations: HQ: Chicago, IL - Biologics & Biosimilars, Monoclonal Antibody Xentria COO Kirsten Anderson and Meitheal CEO and president of Xentria Tom Shea ... Crain Communications, Inc. All Rights Reserved.